We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
story of the week
Published in Lung Cancer

Journal Scan / Research · August 10, 2021

Atezolizumab vs Platinum-Based Chemotherapy for NSCLC

Journal of Thoracic Oncology

 

Additional Info

Journal of Thoracic Oncology
Updated Overall Survival Analysis From IMpower110: Atezolizumab versus Platinum-Based Chemotherapy in Treatment-Naive PD-L1-Selected Non-Small Cell Lung Cancer
J Thorac Oncol 2021 Jul 12;[EPub Ahead of Print], J Jassem, F de Marinis, G Giaccone, A Vergnenegre, CH Barrios, M Morise, E Felip, C Oprean, YC Kim, Z Andric, S Mocci, I Enquist, K Komatsubara, M McCleland, H Kuriki, M Villalobos, S Phan, DR Spigel, RS Herbst

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading